Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
about
Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivoThe tumor microenvironment shapes hallmarks of mature B-cell malignancies.Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: a systematic review and meta-analysis.Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trialHemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma.Novel anti-myeloma agents and angiogenesis.Molecularly targeted therapies in multiple myelomaRole of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic Switch.Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells.Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent.Levels of bone marrow microvessel density are crucial for evaluating the status of acute myeloid leukemia.The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide.
P2860
Q24670297-9B57EBC4-EB4C-401E-8785-B8216461F619Q27687567-69E50B4E-8CEB-4015-AC7E-8E47D182214BQ35104606-8EFC9AB6-0E88-4035-93BC-6A7247461EB6Q35736586-6AF0F569-602D-4B8E-AD1B-D7AAABD74D2CQ36420952-8092187F-14B5-4994-8429-55E3EA586219Q37132903-54B6D208-BBDA-4E98-B132-035A0F13E8B0Q38211866-F902792C-C911-4493-8905-F6833A1305D1Q38970580-95E5F04B-A28E-46A0-A1C4-0B42EC81F0CFQ39377326-E2803C14-EC11-430F-B36A-442D72491DCAQ39443134-285B2D8B-D48E-4ED6-89F0-7CFFADC63934Q39697464-58475216-5BCE-4E36-B388-D8D54D2A1BDDQ40741428-4C6C552F-363D-4197-A801-1B20A2355142Q46600666-3BF21C32-2E2F-410B-870C-D2E7BB41B818
P2860
Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Tumor angiogenesis in the bone ...... tion by thalidomide treatment.
@en
Tumor angiogenesis in the bone ...... tion by thalidomide treatment.
@nl
type
label
Tumor angiogenesis in the bone ...... tion by thalidomide treatment.
@en
Tumor angiogenesis in the bone ...... tion by thalidomide treatment.
@nl
prefLabel
Tumor angiogenesis in the bone ...... tion by thalidomide treatment.
@en
Tumor angiogenesis in the bone ...... tion by thalidomide treatment.
@nl
P2093
P2860
P1476
Tumor angiogenesis in the bone ...... tion by thalidomide treatment.
@en
P2093
Akinori Hashiguchi
Jun-ichi Hata
Kensuke Kondoh
Michiie Sakamoto
Nobumichi Hozumi
Taketo Yamada
Yasuo Ikeda
Yutaka Hattori
P2860
P304
P356
10.1111/J.1440-1827.2004.01622.X
P577
2004-05-01T00:00:00Z